To validate the elevated Wee1 and CDK1 expression of EGFRvIII+ cells in human GBM, we analyzed primary patient tissue, using GBM samples displaying typical heterogeneous EGFRvIII expression. This evidence concerns the gene CDK1 and glioblastoma.